about
Factors associated with choice of exposure therapy for PTSDCharacteristics and Components of the TADS CBT ApproachChanges in emotion regulation in adults with and without a history of childhood abuse following posttraumatic stress disorder treatmentAre PTSD treatment choices and treatment beliefs related to depression symptoms and depression-relevant treatment rationales?Comparing diagnostic checklists for pediatric bipolar disorder in academic and community mental health settings.Recovery and recurrence following treatment for adolescent major depression.Predictors and moderators of agreement between clinical and research diagnoses for children and adolescents.Internal consistency and associated characteristics of informant discrepancies in clinic referred youths age 11 to 17 years.Somatic treatment for depressive illnesses in children and adolescents.5HTTLPR predicts left fusiform gyrus activation to positive emotional stimuli.Examining the validity of cyclothymic disorder in a youth samplePhysical and sexual abuse and early-onset bipolar disorder in youths receiving outpatient services: frequent, but not specific.Changes in negative beliefs following three brief programs for facilitating recovery after assault.Teaching Trauma-Focused Exposure Therapy for PTSD: Critical Clinical Lessons for Novice Exposure Therapists.The impact of PTSD treatment on the cortisol awakening responseThe impact of prolonged exposure on PTSD symptoms and associated psychopathology in people living with HIV: a randomized test of concept.Understanding the relationship between co-occurring PTSD and MDD: symptom severity and affect.Informants are not all equal: predictors and correlates of clinician judgments about caregiver and youth credibility.What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking women.Predictors of health-related quality-of-life utilities among persons with posttraumatic stress disorder.Providing a treatment rationale for PTSD: does what we say matter?A preliminary investigation of sudden gains in exposure therapy for PTSD.What you believe is what you want: modeling PTSD-related treatment preferences for sertraline or prolonged exposureInformant discrepancies in clinical reports of youths and interviewers' impressions of the reliability of informants.Understanding factors associated with early therapeutic alliance in PTSD treatment: adherence, childhood sexual abuse history, and social supportUnique Ethical Concerns in Clinical Trials Comparing Psychosocial and Psychopharmalogical Interventions.An Investigation of Depression, Trauma History, and Symptom Severity in Individuals Enrolled in a Treatment Trial for Chronic PTSD.Sequential treatment for child abuse-related posttraumatic stress disorder: methodological comment on Cloitre, Koenen, Cohen, and Han (2002).Onset of alcohol or substance use disorders following treatment for adolescent depression.Examining PTSD treatment choice among individuals with subthreshold PTSD.The Enhancement of Natural Resilience in Trauma Interventions.The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression.The effects of positive patient testimonials on PTSD treatment choice.The effects of prolonged exposure and sertraline on emotion regulation in individuals with posttraumatic stress disorderImpact of Irritability and Impulsive Aggressive Behavior on Impairment and Social Functioning in Youth with Cyclothymic DisorderPredictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).An exploratory analysis of the impact of family functioning on treatment for depression in adolescents.Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT).Changes in temporal attention inhibition following prolonged exposure and sertraline in the treatment of PTSDReasons underlying treatment preference: an exploratory study
P50
Q24633109-DC1D6643-8EFE-45AB-8252-A4AC5A292C7AQ24670955-2CCF3323-3BFD-4335-8582-FB77D81768D5Q33969159-0780F246-E7FB-4AB1-8ADB-339DBE9C9D76Q34232131-B34005F8-A8DA-4CB0-A7E3-699C47B225DCQ34482994-8F28243A-DABD-4716-A303-725F12A53BCDQ34780705-036787C3-D9B9-49C4-9DF1-30273A1260F6Q34783443-6A226476-A122-4D42-AC6B-C2D468100102Q34807099-D4143CB1-046F-433B-B191-5AC24D525555Q34834210-B8C0ED2C-ABF5-4A1B-A90A-D7D8C0379E1FQ34929279-2170D7EF-3D93-4BE0-8F1D-F0D977005865Q35028008-3C0BD62E-887E-43D2-BFFD-722249A5475DQ35085805-B3CE3D89-0A74-48CC-9F70-22460BB8008AQ35112111-691AE87E-6C87-4B06-8223-B6172551A005Q35282785-932F5046-CD87-4D3A-9A29-8E1F24301691Q35299275-47E24D31-ED6A-4E04-B34A-81B2E7D51C4CQ35346318-F2168C10-EFF2-46C3-A5BC-09CBF977BA19Q35380651-AFC18C4D-8C5D-437D-9570-D83EF8F5C9B6Q35496309-2680C07A-C534-4D0F-96B1-719AE762507AQ35603068-C1AFE3D4-25E3-4D0B-8B8B-C9E3408378FDQ35615199-5C64EE26-BA76-4CC2-84AD-E65893A98A2EQ35620802-5F05E614-C131-4514-B22B-340172875A3BQ35620807-438FE86A-6151-4F09-B706-621FD5B30BD6Q35620811-D09AB0F0-94BB-4C62-B157-CAF682F5D703Q35625901-1BF09717-9FEF-446E-AA3C-E62863B58EF2Q35628140-AF2D8360-4C92-4A22-A5C5-8E7FDA2627DCQ35659634-8191693D-0AAC-4B50-8C8A-EB489441BE5AQ35705921-745CD028-BAF3-4E74-AFA2-CCE782EC814FQ35848002-DF0DB739-5A86-4B6A-8C1F-7632ACB463F7Q35856922-4458CD51-F724-43CB-B5BE-3F74F9FEC4F7Q36068961-396FFE23-50FE-4C5B-9ABC-CB07CD81BAFEQ36399182-B701FD97-4C55-4A64-B80D-7FC00C3E3352Q36428441-CFC77878-E158-4D75-B25F-FB4DA2CB0588Q36458877-6B57D27F-B39C-4BB7-8C57-60A8C08C9644Q36578010-79563AB9-54B9-47FC-98D8-4CEB5623DB09Q36654459-D4FA81F5-7E94-4799-B3AE-C1AF13F428C7Q36669012-90BAEFA7-AD75-42E0-938E-A5BF38215BF5Q36720893-215BAEB6-C8BE-421A-AED4-B8267E9AB138Q36794039-8251E5B1-A09A-4BFD-BCF7-990A74462DDBQ36813518-C13C1159-FAF0-4920-BCE2-BB2E2435C1AFQ36974855-88F29FC5-0277-4E86-A76B-0E8A57B485C9
P50
name
Norah C Feeny
@en
Norah C Feeny
@nl
type
label
Norah C Feeny
@en
Norah C Feeny
@nl
prefLabel
Norah C Feeny
@en
Norah C Feeny
@nl